Sign in
Explore the registryTrack Guselkumab 100 mg's trials

VOYAGE 1

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Guselkumab 100 mgCompletedCompletedPhase 3Open NCT02207231 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…